Laxminarayan has worked with the World Health Organization (WHO) and the World Bank on evaluating malaria treatment policy, vaccination strategies, the economic burden of tuberculosis, and control of non-communicable diseases. He has served on a number of advisory committees at WHO, Centers for Disease Control and Prevention, and the Institute of Medicine. In 2003-04, he served on the National Academy of Science/Institute of Medicine Committee on the Economics ofAntimalarial Drugs and subsequently helped create the Affordable Medicines Facility for malaria, a novel financing mechanism for antimalarials. His work has been covered in major media outlets including Associated Press, BBC, CNN, the Economist, LA Times, NBC,NPR, Reuters, Science, Wall Street Journal, and National Journal.
- The Coming Crisis in Antibiotics
Antibiotic drugs save lives. But we simply use them too much — and often for non-lifesaving purposes, like treating the flu and even raising cheaper chickens. The result, says researcher Ramanan Laxminarayan, is that the drugs will stop working for everyone, as the bacteria they target grow more and more resistant. He calls on all of us (patients and doctors alike) to think of antibiotics — and their ongoing effectiveness — as a finite resource, and to think twice before we tap into it. It's a sobering look at how global medical trends can strike home.